Strs Ohio Has $16.08 Million Stock Holdings in Cencora, Inc. $COR

Strs Ohio trimmed its holdings in Cencora, Inc. (NYSE:COR) by 4.7% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 51,180 shares of the company’s stock after selling 2,506 shares during the period. Strs Ohio’s holdings in Cencora were worth $16,078,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of COR. Kemnay Advisory Services Inc. bought a new position in shares of Cencora during the 4th quarter valued at $25,000. Oakworth Capital Inc. bought a new stake in Cencora in the fourth quarter worth $26,000. Elyxium Wealth LLC acquired a new position in Cencora during the fourth quarter worth $27,000. Archer Investment Corp increased its position in Cencora by 134.3% during the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after buying an additional 47 shares during the last quarter. Finally, Motiv8 Investments LLC bought a new position in Cencora during the fourth quarter valued at about $29,000. Institutional investors and hedge funds own 97.52% of the company’s stock.

Insider Transactions at Cencora

In other Cencora news, Director Lauren M. Tyler purchased 550 shares of the company’s stock in a transaction on Monday, June 22nd. The shares were bought at an average cost of $270.23 per share, with a total value of $148,626.50. Following the transaction, the director directly owned 4,359 shares in the company, valued at approximately $1,177,932.57. This represents a 14.44% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.38% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on COR shares. Citigroup reduced their price target on Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Wells Fargo & Company lowered their price objective on Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a report on Monday, May 11th. Evercore set a $360.00 price objective on Cencora in a research note on Wednesday, April 8th. Bank of America boosted their target price on Cencora from $280.00 to $285.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Finally, Leerink Partners reaffirmed an “outperform” rating on shares of Cencora in a research report on Tuesday, March 17th. Eleven research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $367.75.

Cencora Stock Down 0.0%

Cencora stock opened at $296.43 on Friday. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The firm has a fifty day moving average price of $277.91 and a two-hundred day moving average price of $320.37. The firm has a market cap of $57.67 billion, a price-to-earnings ratio of 22.73, a P/E/G ratio of 1.65 and a beta of 0.58.

Cencora (NYSE:COR) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). The business had revenue of $78.36 billion during the quarter, compared to analyst estimates of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. The company’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same period in the prior year, the business posted $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, analysts forecast that Cencora, Inc. will post 17.79 earnings per share for the current year.

Cencora announced that its Board of Directors has initiated a stock repurchase program on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to buy up to 3.9% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s management believes its stock is undervalued.

Cencora Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were issued a $0.60 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a yield of 0.8%. Cencora’s dividend payout ratio (DPR) is 18.40%.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.